文献速递脊柱关节炎

单细胞分析揭示衰老骨髓间充质干细胞亚群驱动强直性脊柱炎病理性骨化

Single-cell profiling reveals senescent bone marrow mesenchymal stem cell subpopulations driving pathological ossification in ankylosing spondylitis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究对12例强直性脊柱炎(AS)患者的骨髓间充质干细胞(BMSC)进行单细胞RNA测序,按结构损伤程度分为严重结构损伤组(SSD,n=9)和无结构损伤组(NSD,n=3),分析47 628个细胞。发现一个衰老相关亚群(SRC)在晚期韧带骨赘患者中占主导,具有衰老与高代谢双重表型,并计算预测JAK抑制剂可能逆转该致病特征。

要点

  • 单细胞测序揭示AS患者BMSC存在8个亚群,其中衰老相关亚群(SRC)与晚期韧带骨赘相关。
  • SRC高表达MMP2和IL-6,基因特征(CDR1、PLPPR2、CMBL、SRXN1、PPP1R3C)连接氧化应激与异常分化。
  • 计算预测JAK抑制剂(巴瑞替尼、非戈替尼)可能减轻SRC表型。

核心结论

  • 本研究识别出一个与AS结构进展密切相关的衰老相关高代谢BMSC亚群,为病理性骨形成提供细胞基础,并提示JAK抑制剂可能逆转该致病特征。

研究设计与样本

  • 对12例AS患者(SSD组n=9,NSD组n=3)的BMSC进行单细胞RNA测序,基于mSASSS和SPARCC-SSS评估分组。
  • 质控后对47 628个细胞进行无监督聚类、轨迹推断、代谢分析、通路富集和计算机药物筛选。

主要发现

  • 分析揭示8个BMSC亚群,形成从祖细胞到定向祖细胞的连续谱。
  • 衰老相关簇(SRC)在晚期韧带骨赘患者中为主要群体,表现为细胞衰老和高代谢(糖酵解和氧化磷酸化升高)。
  • SRC支持基质重塑因子(MMP2)和炎性细胞因子(IL-6)的分泌。
  • 基因特征(CDR1、PLPPR2、CMBL、SRXN1和PPP1R3C)将氧化应激与异常分化轨迹联系起来。
  • 计算机预测提示JAK抑制剂(巴瑞替尼和非戈替尼)可能减轻SRC表型。

关键数值与推荐

  • 依据mSASSS和SPARCC-SSS评估将患者分为严重结构损伤(SSD,n=9)和无结构损伤(NSD,n=3)组。
  • SRC基因特征包含CDR1、PLPPR2、CMBL、SRXN1和PPP1R3C。
  • 计算预测JAK抑制剂(巴瑞替尼和非戈替尼)为潜在治疗药物。

临床怎么用

  • SRC及其基因特征可能作为评估AS结构进展风险的生物标志物。
  • JAK抑制剂(巴瑞替尼、非戈替尼)或可靶向SRC表型,但需临床验证。

局限性

  • 样本量较小(SSD组n=9,NSD组n=3),结论需扩大样本验证。
  • JAK抑制剂的治疗潜力仅基于计算机预测,缺乏实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aberrant new bone formation is a hallmark of ankylosing spondylitis (AS), yet the cellular mechanisms remain unclear. Bone marrow-derived mesenchymal stem cells (BMSCs) are crucial for skeletal homeostasis and may be pathologically reprogrammed under chronic inflammation. We aimed to characterize the cellular heterogeneity and differentiation states of BMSCs in AS, identify BMSC subpopulations associated with structural damage, and explore their molecular features and potential therapeutic targets. METHODS: Single-cell RNA sequencing was performed on BMSCs from 12 AS patients stratified into severe structural damage (SSD, n = 9) and no structural damage (NSD, n = 3) groups based on mSASSS and SPARCC-SSS assessments. After quality control, 47 628 cells were analysed by unsupervised clustering, trajectory inference, metabolic profiling, pathway enrichment and in silico drug screening to characterize pathogenic subpopulations. RESULTS: The analysis revealed eight BMSC subpopulations forming a continuum from progenitors to lineage-committed cells. A distinct senescence-related cluster (SRC) was identified as the predominant population in patients with advanced syndesmophytes. The SRC displayed a dual phenotype of cellular senescence and hyperactive metabolism, characterized by elevated glycolysis and oxidative phosphorylation. This state supported the secretion of matrix-remodeling factors (MMP2) and inflammatory cytokines (IL-6). A specific gene signature (CDR1, PLPPR2, CMBL, SRXN1 and PPP1R3C) linked oxidative stress to this aberrant differentiation trajectory. Furthermore, computational prediction highlighted JAK inhibitors (baricitinib and filgotinib) as potential therapeutics to attenuate the SRC phenotype. CONCLUSION: This study identifies a senescence-associated, hypermetabolic BMSC subpopulation that is closely associated with structural progression in AS, providing a cellular basis for pathological bone formation and suggests that JAK inhibitors may serve as effective agents to reverse this pathogenic BMSC signature.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Luo X, Li J, Qi J, et al. Single-cell profiling reveals senescent bone marrow mesenchymal stem cell subpopulations driving pathological ossification in ankylosing spondylitis. Rheumatology (Oxford). 2026. PMID: 42635554. doi:10.1093/rheumatology/keag429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。